Piotr Kosla, founder of the PACS2 Research Foundation, joins us to discuss his personal motivation to develop the first treatment for Development and Epileptic Encephalopathy 66 (PACS2 Syndrome), how cell painting assays are being used to repurpose a treatment for this condition, what the future holds for research in this area, and how you can help contribute to his mission.

Show Notes

• PACS2 Research Foundation 
• Eureka Blog | Drug Repurposing Through Cell Painting Could Treat Rare Disease 
• ASO Screening Services
• Gene Therapy Services 
• Art of Science: Cell Painting 
• Free for Life: The Story of n-Lorem Foundation